Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 7/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL85637 | 1.00 | ALDH1A1 (0.56) | ALDH1A1GAATSHRF10DPP4 | |
| SCHEMBL21227837 | 0.85 | ALDH1A1 (0.58) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL1972508 | 0.81 | MEN1 (0.62) | F10MEN1KMT2A | |
| SCHEMBL29629027 | 0.80 | ALDH1A1 (0.57) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL28721342 | 0.79 | GAA (0.59) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL28721339 | 0.79 | GAA (0.59) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL3948456 | 0.79 | ALDH1A1 (0.85) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL381922 | 0.79 | ALDH1A1 (0.85) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL3948461 | 0.79 | ALDH1A1 (0.85) | ALDH1A1GAATSHRDPP4DPP7 | |
| SCHEMBL20064375 | 0.78 | ALDH1A1 (0.58) | ALDH1A1GAATSHRDPP4DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11053234-B2 | 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2021-07-06 | — | — | US | disclosed |
| US-20190241554-A1 | 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11053234-B2 | 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors | HPGDS, PTGDR, PTGER1 | ALDH1A1 222/4885GAA 568/4885TSHR 3838/4885 |
| US-20190241554-A1 | 1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS | HPGDS, PTGDR, PTGER1 | ALDH1A1 222/4885GAA 568/4885TSHR 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.